Drug Shortage Report for MYLAN-OMEPRAZOLE
Report ID | 235 |
Drug Identification Number | 02329425 |
Brand name | MYLAN-OMEPRAZOLE |
Common or Proper name | OMEPRAZOLE |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | OMEPRAZOLE |
Strength(s) | 10MG |
Dosage form(s) | CAPSULE (DELAYED RELEASE) |
Route of administration | ORAL |
Packaging size | 30BT |
ATC code | A02BC |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2018-05-01 |
Estimated end date | Unknown |
Actual end date | 2018-08-16 |
Shortage status | Resolved |
Updated date | 2018-08-27 |
Company comments | Discontinued in ID 52267 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.